A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
M. Osman, A. Mistry, A. Keding, R. Gabe +11 more
2017PLoS Neglected Tropical Diseases137 citations Open access
Semantic Scholar

